{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-006618","form_type":"8-K","ticker":"ITGR","cik":"0001114483","company_name":"Integer Holdings Corp","filed_at":"2025-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.823814+00:00","generated_at":"2026-05-17T02:25:58.633510+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Integer Q3 sales up 8% to $468M; non-GAAP EPS $1.79, up 25% YoY; updates 2025 outlook","bullets":["GAAP diluted EPS from continuing ops $1.11 (+10% YoY); non-GAAP adjusted EPS $1.79 (+25%).","Non-GAAP adjusted operating income $86M (+14%); adjusted EBITDA $106M (+11%).","Cardio & Vascular sales up 15% YoY; Other Markets down 16% on planned portable medical exit.","Total debt increased $204M to $1.194B, primarily for acquisitions and convertible note offering.","2025 sales guidance raised to $1.84-1.854B (7-8% growth); adjusted EPS outlook $6.29-6.43."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-006618","json":"https://secwatch.observer/filing/0001171843-25-006618.json","markdown":"https://secwatch.observer/filing/0001171843-25-006618.md","text":"https://secwatch.observer/filing/0001171843-25-006618.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1114483/000117184325006618/0001171843-25-006618-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1114483/000117184325006618/f8k_102225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:25:58.633510+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}